EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹4.52 Cr | ₹4.15 Cr | ₹3.89 Cr | ₹3.58 Cr | ₹3.05 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EVEREST ORGANICS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹4.52 Cr |
Mar2023 | ₹4.15 Cr |
Mar2022 | ₹3.89 Cr |
Mar2021 | ₹3.58 Cr |
Mar2020 | ₹3.05 Cr |
How is Deferred Tax Assets / Liabilities of EVEREST ORGANICS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.52 Cr | 8.95 | |
Mar2023 | ₹4.15 Cr | 6.61 | |
Mar2022 | ₹3.89 Cr | 8.54 | |
Mar2021 | ₹3.58 Cr | 17.67 | |
Mar2020 | ₹3.05 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹307.8 Cr | -1% | -3.8% | 115.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -1% |
-3.8% |
115.2% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses